About
Thomas Carroll is a cancer researcher with expertise in bioinformatics, biomarkers, and methods development who is now building diagnostics at Numen.
Tom Carroll @_tom_dot_com
Follow me to see if the vibe-folded brackets can bring home first place, and for more on what else we can do with these models 😎
Mar 20, 2026 · ♥ 2
Tom Carroll @_tom_dot_com
So how good are these predictions? Mercifully, this strat only picked 3/8 possible 16 seed upsets. Through Day 1 of the men’s bracket, we're not too shabby! Picked some key upsets from #12 High Point, #11 Texas, and #11 VCU. Must be some bball training data somewhere in UniRef. https://t.co/PSHe1SBfm5

Mar 20, 2026 · ♥ 2
Tom Carroll @_tom_dot_com
Many high-ranking teams formed long helical structures, which I took to be signs of a well-organized team. The top-ranked team by far was Duke women’s (Avg pLDDT 77), with a full-team coiled structure that even InterProScan had to give props to. Clear sign of intrinsic cohesion. https://t.co/KwRpOKSvb2


Mar 20, 2026 · ♥ 1
Founder at NumenYC S23
Intro paths
Thomas went through Y Combinator (Summer 2023) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Ankit Gupta, General Partner at Y Combinator — the partner who ran Numen's batch and knows the company first-hand. YC profile ↗
In turn, Thomas can intro founders to Numen's investors below.
